Outcome
Type |
Measure |
Description |
Time frame |
Safety issue |
Primary |
Constant-Murley Score |
The functional level will be assessed by the Constant Murley Score, which is a 100-point scale consisting of 15 points for pain, 20 points for daily activities, 40 points for pain-free range of motion, and 25 points for strength. High scores are positively correlated with the increased functional level. While pain and activities of daily living are evaluated by the patient, range of motion and strength are evaluated by the clinician. |
Baseline |
|
Secondary |
Constant-Murley Score |
The functional level will be assessed by the Constant Murley Score, which is a 100-point scale consisting of 15 points for pain, 20 points for daily activities, 40 points for pain-free range of motion, and 25 points for strength. High scores are positively correlated with the increased functional level. While pain and activities of daily living are evaluated by the patient, range of motion and strength are evaluated by the clinician. |
At the end of 8-week intervention |
|
Secondary |
Visual Analogue Scale (VAS) |
Pain intensity will be measured using the visual analogue scale (VAS). The participants will be asked to indicate their perceived pain at rest, during activity and at night on the 10 cm line between no pain and terrible pain. The score will be determined by measuring the distance on 10 cm line using a ruler. The higher scores indicate an higher level of pain. |
Baseline |
|
Secondary |
Visual Analogue Scale (VAS) |
Pain intensity will be measured using the visual analogue scale (VAS). The participants will be asked to indicate their perceived pain at rest, during activity and at night on the 10 cm line between no pain and terrible pain. The score will be determined by measuring the distance on 10 cm line using a ruler. The higher scores indicate an higher level of pain. |
At the end of 8-week intervention |
|
Secondary |
Active Range of Motion (AROM) Assessment |
The shoulder flexion, abduction, internal and external rotation ROM will be measured described by the American Academy of Orthopaedic Surgeons (AAOS) using a digital goniometer. The process will be repeated three times in each direction, with the average value recorded. |
Baseline |
|
Secondary |
Active Range of Motion (AROM) Assessment |
The shoulder flexion, abduction, internal and external rotation ROM will be measured described by the American Academy of Orthopaedic Surgeons (AAOS) using a digital goniometer. The process will be repeated three times in each direction, with the average value recorded. |
At the end of 8-week intervention |
|
Secondary |
Pain Catastrophizing Scale (PCS) |
Pain catastrophizing, which is characterized by the tendency to magnify the threat value of a pain stimulus and to feel helpless in the presence of pain, as well as by a relative inability to prevent or inhibit pain-related thoughts in anticipation of, during, or following a painful event will be measured using the Pain Catastrophizing Scale (PCS). |
Baseline |
|
Secondary |
Pain Catastrophizing Scale (PCS) |
Pain catastrophizing, which is characterized by the tendency to magnify the threat value of a pain stimulus and to feel helpless in the presence of pain, as well as by a relative inability to prevent or inhibit pain-related thoughts in anticipation of, during, or following a painful event will be measured using the Pain Catastrophizing Scale (PCS). |
At the end of the 8-week intervention |
|
Secondary |
The Hospital Anxiety and Depression Scale (HADS) |
The anxiety and depression will be assessed using the Pain Catastrophizing Scale (PCS), which is used to measure anxiety and depression in a general medical population of patients. |
Baseline |
|
Secondary |
The Hospital Anxiety and Depression Scale (HADS) |
The anxiety and depression will be assessed using the Pain Catastrophizing Scale (PCS), which is used to measure anxiety and depression in a general medical population of patients. |
At the end of the 8-week intervention |
|
Secondary |
Pittsburgh Sleep Quality Index (PSQI) |
The anxiety and depression will be assessed using the Pittsburgh Sleep Quality Index (PSQI), which is a self-rated questionnaire which assesses sleep quality and disturbances over a 1-month time interval. |
Baseline |
|
Secondary |
Pittsburgh Sleep Quality Index (PSQI) |
The anxiety and depression will be assessed using the Pittsburgh Sleep Quality Index (PSQI), which is a self-rated questionnaire which assesses sleep quality and disturbances over a 1-month time interval. |
At the end of the 8-week intervention |
|
Secondary |
Short Form-12 (SF-12) |
Health related quality of life will be assessed using the SF-12 is a self-reported outcome measure assessing the impact of health on an individual's everyday life. It is often used as a quality of life measure. |
Baseline |
|
Secondary |
Short Form-12 (SF-12) |
Health related quality of life will be assessed using the SF-12 is a self-reported outcome measure assessing the impact of health on an individual's everyday life. It is often used as a quality of life measure. |
At the end of the 8-week intervention |
|
Secondary |
Global Rating of Change (GRC) |
Patient satisfaction regarding improvement in shoulder function will be assessed by the Global Rating of Change (GRC) scale. The patients will be asked to rate their condition after a 8-week intervention period compared to baseline by indicating whether they have improved significantly, improved slightly, unchanged, deteriorated slightly, or deteriorated significantly in this study. |
At the end of the 8-week intervention |
|
Secondary |
Exercise Dairy |
A self reported adherence to home exercise program will be assessed using the exercise dairy. |
At the end of the 8-week intervention |
|